ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,250Medicare Part D Prescriptions Filled, Including Refills

Rank: 134 out of 1692

$771K Total Retail Price of All Prescriptions

Rank: 80 out of 1692

509 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 509 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,969 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 497 457 1 3
PRAVASTATIN SODIUM 406 350 2 12
HYDROCODONE-ACETAMINOPHEN 329 219 S3 3 6
OMEPRAZOLE 322 292 4 5
PANTOPRAZOLE SODIUM 302 261 5 39
SIMVASTATIN 276 240 6 1
LEVOTHYROXINE SODIUM 271 210 7 4
METFORMIN HCL 250 204 8 8
LISINOPRIL 227 172 9 2
LOSARTAN POTASSIUM 210 185 10 17
CITALOPRAM HBR 183 133 11 21
HYDROCHLOROTHIAZIDE 176 140 12 9
ZOLPIDEM TARTRATE 173 96 13 23
LOSARTAN-HYDROCHLOROTHIAZIDE 149 135 14 38
CRESTOR 142 109 15 26
FUROSEMIDE 139 121 16 7
WARFARIN SODIUM 137 129 17 14
ATORVASTATIN CALCIUM 133 114 18 11
BUMETANIDE 130 108 19 125
BENAZEPRIL HCL 129 128 20 69
AMLODIPINE BESYLATE-BENAZEPRIL 122 122 21 67
ALENDRONATE SODIUM 109 97 22 36
CELEBREX 103 83 23 103
EXELON 101 101 24 187
ATENOLOL 101 86 24 15
BYSTOLIC 100 97 26 129
GLIMEPIRIDE 98 92 27 32
METOPROLOL TARTRATE 98 88 27 10
GABAPENTIN 96 76 29 13
PREDNISONE 95 77 30 35
METOPROLOL SUCCINATE 93 76 31 18
AZITHROMYCIN 92 70 32 34
TRAZODONE HCL 90 44 33 33
TRAMADOL HCL 89 42 34 16
DIOVAN 88 86 35 42
POTASSIUM CHLORIDE 88 83 35 20
ADVAIR DISKUS 87 79 37 45
SPIRIVA 86 76 38 44
SERTRALINE HCL 82 70 39 22
CIPROFLOXACIN HCL 82 76 39 65
CLOPIDOGREL 82 70 39 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 78 42 19
METFORMIN HCL ER 77 71 43 49
NABUMETONE 77 58 43 158
NAMENDA 76 70 45 50
DIGOXIN 71 68 46 85
NEXIUM 69 43 47 25
CYCLOBENZAPRINE HCL 69 19 R 47 54
FLUTICASONE PROPIONATE 69 65 47 27
BUPROPION XL 67 42 50 235
FENOFIBRATE 67 53 50 63
CEFUROXIME 66 49 52 153
PRAMIPEXOLE DIHYDROCHLORIDE 65 54 53 216
DIOVAN HCT 64 44 54 73
DILTIAZEM 24HR ER 60 42 55 134
TAMSULOSIN HCL 60 60 55 31
WELCHOL 59 59 57 217
PLAVIX 59 52 57 66
CLONIDINE HCL 58 40 59 46
SINGULAIR 57 41 60 79
DILTIAZEM ER 55 55 61 174
DONEPEZIL HCL 53 49 62 29
SYMBICORT 52 35 63 166
ACTOS 51 38 64 117
DOXYCYCLINE HYCLATE 51 33 64 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.